234318531	234318531	CD	B-NP	O
|	|	NN	I-NP	O
CHO	CHO	NN	I-NP	O
|	|	NN	I-NP	O
47380282	47380282	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
387058	387058	CD	B-NP	O
|	|	CC	I-NP	O
1/21/2000	1/21/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ANGINA	ANGINA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/27/2000	3/27/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/24/2000	7/24/2000	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
MYOCARDIAL	MYOCARDIAL	JJ	B-NP	O
INFARCTION	INFARCTION	NN	I-NP	O
.	.	.	O	O

SIGNIFICANT	SIGNIFICANT	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

HYPERCHOLESTEROLEMIA	HYPERCHOLESTEROLEMIA	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

ANEMIA	ANEMIA	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Christin	Christin	NNP	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
female	female	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
states	state	VBZ	B-VP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
she	she	PRP	B-NP	O
felt	feel	VBD	B-VP	O
some	some	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
tightness	tightness	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
upon	upon	IN	B-PP	O
laying	lay	VBG	B-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

She	She	PRP	B-NP	O
took	take	VBD	B-VP	O
one	one	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
Nitroglycerin	Nitroglycerin	NN	I-NP	O
without	without	IN	B-PP	O
relief	relief	NN	B-NP	O
.	.	.	O	O

Thirty	Thirty	CD	B-NP	O
minutes	minute	NNS	I-NP	O
later	later	RB	B-ADVP	O
took	take	VBD	B-VP	O
another	another	DT	B-NP	O
sublingual	sublingual	JJ	I-NP	O
Nitroglycerin	Nitroglycerin	NN	I-NP	O
,	,	,	O	O
again	again	RB	B-ADVP	O
without	without	IN	B-PP	O
relief	relief	NN	B-NP	O
.	.	.	O	O

Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
was	be	VBD	B-VP	O
accompanied	accompany	VBN	I-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
feeling	feeling	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
tightness	tightness	NN	I-NP	O
rated	rat	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
8/10	8/10	CD	I-NP	O
.	.	.	O	O

Took	Took	VB	B-VP	O
a	a	DT	B-NP	O
third	third	JJ	I-NP	O
Nitroglycerin	Nitroglycerin	NN	I-NP	O
without	without	IN	B-PP	O
relief	relief	NN	B-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
her	her	PRP$	B-NP	O
breathing	breathing	NN	I-NP	O
became	become	VBD	B-VP	O
wheezy	wheezy	WRB	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
then	then	RB	B-ADVP	O
drove	drive	VBD	B-VP	O
herself	herself	PRP	B-NP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
there	there	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
Lasix	Lasix	NN	I-NP	O
,	,	,	O	O
morphine	morphine	NN	B-NP	O
and	and	CC	O	O
Nitroglycerin	Nitroglycerin	NN	B-NP	B-protein
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
at	at	IN	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
showed	show	VBD	B-VP	O
anterolateral	anterolateral	JJ	B-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
ruling	rule	VBG	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
cardiac	cardiac	JJ	B-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
and	and	CC	I-NP	O
age	age	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
symptomatology	symptomatology	NN	I-NP	O
began	begin	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fall	fall	NN	I-NP	O
of	of	IN	B-PP	O
1999	1999	CD	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
experience	experience	VB	I-VP	O
chest	chest	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	I-NP	O
rest	rest	NN	I-NP	O
.	.	.	O	O

Evaluation	Evaluation	NN	B-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jose	Jose	NNP	I-NP	O
Esparza	Esparza	NNP	I-NP	O
showed	show	VBD	B-VP	O
high	high	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
LDL	LDL	NN	I-NP	B-DNA
141	141	CD	I-NP	I-DNA
,	,	,	O	O
EKG	EKG	NN	B-NP	B-protein
with	with	IN	B-PP	O
LVH	LVH	NN	B-NP	B-protein
and	and	CC	O	O
nonspecific	nonspecific	JJ	B-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
flattening	flattening	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
Thallium	Thallium	NN	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
August	August	NNP	B-NP	O
of	of	IN	B-PP	O
1999	1999	CD	B-NP	O
was	be	VBD	B-VP	O
three	three	CD	B-NP	O
minutes	minute	NNS	I-NP	O
,	,	,	O	O
fifty-two	fifty-two	CD	B-NP	O
seconds	second	NNS	I-NP	O
duration	duration	NN	I-NP	O
,	,	,	O	O
stopped	stop	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
inferolateral	inferolateral	JJ	B-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
with	with	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
apical	apical	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
on	on	IN	B-PP	O
imaging	imaging	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
managed	manage	VBD	B-VP	O
medically	medically	RB	B-ADVP	O
with	with	IN	B-PP	O
cholesterol	cholesterol	NN	B-NP	O
lowering	lowering	NN	I-NP	O
and	and	CC	O	O
antihypertensive	antihypertensive	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
angina	angina	NN	B-NP	O
,	,	,	O	O
Paget	Paget	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
widowed	widow	VBN	I-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

Has	Has	IN	B-PP	O
many	many	JJ	B-NP	O
friends	friend	NNS	I-NP	O
and	and	CC	I-NP	O
support	support	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

Owns	Owns	NNP	B-NP	O
her	her	PRP$	B-NP	O
own	own	JJ	I-NP	O
store	store	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
orthopnea	orthopnea	NN	B-NP	O
increasing	increase	VBG	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
claudication	claudication	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
syncope	syncope	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
melena	melena	NN	I-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
hemoptysis	hemoptysis	NN	B-NP	O
or	or	CC	O	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
-	-	HYPH	B-NP	O
She	She	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
at	at	IN	B-PP	O
98.3	98.3	CD	B-NP	O
degrees	degree	NNS	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
52	52	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
160/68	160/68	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NNP	B-NP	O
-	-	HYPH	O	O
She	She	NNP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
petite	petite	JJ	I-NP	O
,	,	,	I-NP	O
elderly	elderly	JJ	I-NP	O
woman	woman	NN	I-NP	O
sitting	sit	VBG	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Pupils	Pupil	NNS	I-NP	O
are	be	VBP	B-VP	O
equally	equally	RB	B-ADJP	O
round	round	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
reactive	reactive	JJ	I-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
JV	JV	NN	I-NP	O
pressure	pressure	NN	I-NP	O
approximately	approximately	RB	B-NP	O
6	6	CD	I-NP	O
cm	cm	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
carotids	carotid	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Crackles	Crackle	NNPS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	O
:	:	:	O	O
Distant	Distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

Soft	Soft	JJ	B-NP	O
grade	grade	NN	I-NP	O
I/VI	I/VI	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
gallop	gallop	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
-	-	HYPH	B-NP	O
Soft	Soft	JJ	I-NP	O
,	,	,	I-NP	O
non-tender	non-tender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
masses	mass	NNS	I-NP	O
,	,	,	O	O
guarding	guard	VBG	B-VP	O
or	or	CC	O	O
rebound	rebound	VB	B-VP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NNP	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
Nonfocal	Nonfocal	JJ	B-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
140	140	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
4.4	4.4	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	O
of	of	IN	B-PP	O
459	459	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
of	of	IN	B-PP	O
28.7	28.7	CD	B-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
26.9	26.9	CD	I-NP	I-protein
,	,	,	O	O
platelet	platelet	NN	B-NP	B-protein
count	count	NN	I-NP	I-protein
238	238	CD	I-NP	I-protein
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
60	60	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
with	with	IN	B-PP	O
ST	ST	JJ	B-NP	O
segment	segment	NN	I-NP	O
depression	depression	NN	I-NP	O
V4	V4	NN	I-NP	O
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
and	and	CC	O	O
approximately	approximately	RB	B-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
lead	lead	NN	B-NP	O
II	II	CD	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Dison	Dison	NNP	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Ster	Ster	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
angina	angina	NN	I-NP	O
after	after	IN	B-PP	O
ruling	rule	VBG	B-VP	O
out	out	RB	B-ADVP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
her	her	PRP$	B-NP	O
laboratory	laboratory	NN	I-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
is	be	VBZ	B-VP	O
summarized	summarize	VBN	I-VP	O
as	as	IN	B-PP	O
follows	follow	VBZ	B-VP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Berish	Berish	NNP	I-NP	O
ruled	rule	VBD	B-VP	O
in	in	IN	B-PP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
CK	CK	NN	I-NP	O
of	of	IN	B-PP	O
459	459	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
of	of	IN	B-PP	O
28.7	28.7	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
328	328	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
of	of	IN	B-PP	O
15.4	15.4	CD	B-NP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
was	be	VBD	B-VP	O
15	15	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
remained	remain	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
and	and	CC	O	O
pain	pain	NN	B-NP	O
free	free	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
2000	2000	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
okay	okay	NN	I-NP	O
left	leave	VBD	B-VP	O
main	main	JJ	B-ADJP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	O
with	with	IN	B-PP	O
proximal	proximal	JJ	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
underwent	undergo	VBD	B-VP	O
PTCA	PTCA	NN	B-NP	O
and	and	CC	O	O
stenting	stente	VBG	B-VP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
osteal	osteal	JJ	I-NP	O
D-1	D-1	NN	I-NP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
which	which	WDT	B-NP	O
underwent	undergo	VBD	B-VP	O
PTCA	PTCA	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
totally	totally	RB	I-NP	O
occluded	occlude	VBN	I-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
this	this	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
altered	alter	VBN	I-VP	O
to	to	TO	B-VP	O
include	include	VB	I-VP	O
beta	beta	NN	B-NP	O
blockade	blockade	NN	I-NP	O
,	,	,	O	O
ACE	ACE	NN	B-NP	O
inhibition	inhibition	NN	I-NP	O
and	and	CC	O	O
antihypertensives	antihypertensive	NNS	B-NP	O
and	and	CC	I-NP	O
ischemics	ischemic	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
outlined	outline	VBN	B-VP	O
below	below	IN	B-PP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventriculogram	ventriculogram	NN	B-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
catheterization	catheterization	NN	I-NP	O
showed	show	VBD	B-VP	O
anterior	anterior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ANEMIA	ANEMIA	NN	B-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Flewellen	Flewellen	NNP	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
normochromic	normochromic	JJ	I-NP	O
,	,	,	I-NP	O
normocytic	normocytic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
worked	work	VBN	I-VP	O
up	up	RP	B-PRT	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
26.9	26.9	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Her	Her	PRP$	B-NP	O
workup	workup	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
iron	iron	NN	I-NP	O
of	of	IN	B-PP	O
74	74	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
TIBC	TIBC	NN	I-NP	B-protein
of	of	IN	B-PP	O
244	244	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
ferritin	ferritin	NN	I-NP	B-protein
of	of	IN	B-PP	O
224	224	CD	B-NP	O
,	,	,	O	O
B-12	B-12	NN	B-NP	B-protein
of	of	IN	B-PP	O
241	241	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
borderline	borderline	JJ	I-NP	O
low	low	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
and	and	CC	I-NP	O
Epogen	Epogen	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
TSH	TSH	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
at	at	IN	B-PP	O
2.86	2.86	CD	B-NP	O
,	,	,	O	O
reticulocyte	reticulocyte	NN	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
pending	pende	VBG	I-NP	O
serum	serum	NN	I-NP	O
protein	protein	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Hematology	Hematology	NNP	I-NP	O
Consult	Consult	NNP	I-NP	O
Service	Service	NNP	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Esteves	Esteves	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Hematology	Hematology	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
30	30	CD	B-NP	O
.	.	.	O	O

Ms.	Ms.	NNP	B-NP	O
Bottoni	Bottoni	NNP	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2000	2000	CD	B-NP	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Porter	Porter	NNP	I-NP	O
Luckenbaugh	Luckenbaugh	NNP	I-NP	O
in	in	IN	B-PP	O
SH	SH	NNP	B-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
Group	Group	NNP	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	O	O
00	00	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sammy	Sammy	NNP	I-NP	O
Kleindienst	Kleindienst	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Greenetons	Greenetons	NNP	I-NP	O
Opi	Opi	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Hematology	Hematology	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Hydrochlorothiazide	Hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
daily	daily	NN	I-NP	O
,	,	,	O	O
Relafen	Relafen	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
29	29	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Atenolol	Atenolol	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
orally	orally	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
oxide	oxide	NN	I-NP	O
420	420	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
CLINTON	CLINTON	NNP	B-NP	O
DARVILLE	DARVILLE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
XC88	XC88	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ARNULFO	ARNULFO	NNP	B-NP	O
L.	L.	NNP	I-NP	O
BASNETT	BASNETT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
HD3	HD3	NNP	I-NP	O
FT554/4425	FT554/4425	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
70863	70863	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

N7LJ9S95RI	N7LJ9S95RI	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
6/23	6/23	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/23	6/23	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ANTIONE	ANTIONE	NNP	B-NP	O
R.	R.	NNP	I-NP	O
SULENTIC	SULENTIC	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
HD3	HD3	NN	I-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

VITO	VITO	NNP	B-NP	O
B.	B.	NNP	I-NP	O
LADO	LADO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	B-protein
LB7	LB7	NNP	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

FOREST	FOREST	NNP	B-NP	O
G.	G.	NNP	I-NP	O
NICODEMUS	NICODEMUS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	B-protein
BM2	BM2	NNP	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

DR.	DR.	NNP	B-NP	O
OHRT	OHRT	NNP	I-NP	O
,	,	,	O	O
Ster	Ster	NNP	B-NP	O

